<DOC>
	<DOCNO>NCT00002624</DOCNO>
	<brief_summary>RATIONALE : Video-assisted surgery follow radiation therapy may effective treatment patient whose poor heart lung function make high risk standard surgery . PURPOSE : Phase II trial study effectiveness video-assisted surgery follow radiation therapy treat patient stage I non-small cell lung cancer poor heart lung function .</brief_summary>
	<brief_title>Video-Assisted Surgery Followed Radiation Therapy Treating Patients With Stage I Non-small Cell Lung Cancer Poor Heart Lung Function</brief_title>
	<detailed_description>OBJECTIVES : - Determine feasibility video-assisted thoracoscopic wedge resection ( VAR ) follow radiotherapy patient stage I non-small cell lung cancer cardiopulmonary dysfunction . - Determine incidence locoregional recurrence patient treat regimen . - Determine overall disease-free survival patient treat regimen . - Determine technical feasibility ipsilateral lymph node sample complete resection VAR patient . - Determine incidence conversion open thoracotomy patient . - Determine short- long-term complication associate VAR patient . - Determine toxicity adjuvant radiotherapy VAR patient . OUTLINE : This multicenter study . Patients undergo video-assisted thoracoscopic wedge resection . Surgeons attempt sample identification ipsilateral , mediastinal , hilar lymph node . When accessible , lobar lymph node must also sample . If tumor margin positive , resection margin must attempt . Open thoracotomy may require technical reason .</detailed_description>
	<mesh_term>Lung Neoplasms</mesh_term>
	<mesh_term>Carcinoma , Non-Small-Cell Lung</mesh_term>
	<criteria>DISEASE CHARACTERISTICS : Known suspect , single , peripheral , stage T1 N0 M0 lung tumor Tumor must identifiable bronchoscopy Bronchoscopically visible cancer bronchial distortion consider related tumor Positive cytology bronchoscopy allow gross abnormality visible Mediastinoscopy require node great 1 cm No pleural effusion No metastatic N2 disease CT scan Lesion must accessible videoassisted thoracoscopic wedge resection High cardiopulmonary risk thoracotomy least 1 follow criterion : FEV1 le 40 % predict DLCO le 50 % predict Supplemental oxygen requirement Chronic PaCO2 great 45 mm Hg Maximum oxygen consumption ( VO2 max ) less 15 mL/kg/min Patients appear high risk nonpulmonary reason ( e.g. , patient elderly renal cardiac failure ) may eligible VO2 max criterion meet Eligible radiotherapy completion wedge resection histologic documentation nonsmall cell lung cancer , include follow subtypes : Squamous cell carcinoma Adenocarcinoma Bronchoalveolar cell Large cell anaplastic carcinoma Cytology bronchial washing transthoracic needle aspiration acceptable PATIENT CHARACTERISTICS : Age : 18 Performance status : 02 Other : No malignancy within past 5 year except nonmelanomatous skin cancer carcinoma situ cervix Weight loss great 10 % within past 6 month PRIOR CONCURRENT THERAPY : Radiotherapy No prior thoracic irradiation</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>July 2016</verification_date>
	<keyword>stage I non-small cell lung cancer</keyword>
	<keyword>squamous cell lung cancer</keyword>
	<keyword>large cell lung cancer</keyword>
	<keyword>adenocarcinoma lung</keyword>
	<keyword>bronchoalveolar cell lung cancer</keyword>
</DOC>